A, Y., L, S., KL, A., S, T., HW, S., M, K., . . . A, L. (2025). Clinical outcomes and management of CDKN2A/B homozygously deleted IDH-mutant astrocytomas-a cohort study and patterns of care survey. Neuro-oncology practice, 12(5), 787. https://doi.org/10.1093/nop/npaf045
Chicago Style (17th ed.) CitationA, Yuile, et al. "Clinical Outcomes and Management of CDKN2A/B Homozygously Deleted IDH-mutant Astrocytomas-a Cohort Study and Patterns of Care Survey." Neuro-oncology Practice 12, no. 5 (2025): 787. https://doi.org/10.1093/nop/npaf045.
MLA (9th ed.) CitationA, Yuile, et al. "Clinical Outcomes and Management of CDKN2A/B Homozygously Deleted IDH-mutant Astrocytomas-a Cohort Study and Patterns of Care Survey." Neuro-oncology Practice, vol. 12, no. 5, 2025, p. 787, https://doi.org/10.1093/nop/npaf045.